Clinical Trials Browser

NCT06374459 2026-04-20

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Phase 1/2 Recruiting

152 enrolled

Breast

Breast Neoplasms

NCT04549207 2026-04-07

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Phase 4 Active not recruiting

240 enrolled

Breast

Breast Neoplasms

NCT04067726 2026-03-31

TRIDENT

Phase 2 Active not recruiting

210 enrolled

Breast

Breast Neoplasms

NCT02051218 2025-12-30

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Phase 3 Active not recruiting

1,380 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT04711109 2025-04-02

BRCA-P

Phase 3 Active not recruiting

300 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Phase EARLY_PHASE1 Completed

10 enrolled

Breast

Breast Neoplasms

NCT02613416 2024-08-23

Dmab

Phase 2 Completed

42 enrolled 6 charts

Breast

Breast Neoplasms

NCT03324932 2023-10-06

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Phase 3 Active not recruiting

160 enrolled

Breast

Breast Neoplasms

NCT03691311 2021-11-03

D-BIOMARK

Phase EARLY_PHASE1 Unknown

60 enrolled

Breast

Osteopetrosis, mild autosomal recessive form, Osteopetrosis, Autosomal Recessive 7, Breast Neoplasms

NCT02366130 2021-10-07

Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer

Phase 2 Completed

45 enrolled 7 charts

Breast

Breast Neoplasms

NCT02682693 2021-02-02

GeparX

Phase 2 Completed

780 enrolled

Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT02721433 2020-12-02

REaCT-BTA

Phase 4 Completed

263 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

Phase EARLY_PHASE1 Completed

44 enrolled

Breast

Breast Neoplasms

NCT01952054 2019-11-22

Denosumab for Breast Cancer With Bone Mets

Phase 2 Terminated

7 enrolled 8 charts

Breast

Breast Neoplasms

NCT03811509 2019-01-28

B-ABLE

Phase 4 Unknown

1,000 enrolled

Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Osteoporotic Fractures, Musculoskeletal Pain

NCT01864798 2018-11-27

D-Beyond

Phase 2 Terminated

27 enrolled

Breast

Breast Neoplasms

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase 2 Terminated

1 enrolled 6 charts

Breast

Breast Neoplasms, Neoplastic Cells, Circulating